These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. Coordinated downregulation of KCC2 and GABA Wan L; Chen L; Yu J; Wang G; Wu Z; Qian B; Liu X; Wang Y Biochem Biophys Res Commun; 2020 Nov; 532(3):489-495. PubMed ID: 32892950 [TBL] [Abstract][Full Text] [Related]
49. Loss of non-canonical KCC2 functions promotes developmental apoptosis of cortical projection neurons. Mavrovic M; Uvarov P; Delpire E; Vutskits L; Kaila K; Puskarjov M EMBO Rep; 2020 Apr; 21(4):e48880. PubMed ID: 32064760 [TBL] [Abstract][Full Text] [Related]
50. The Role of K Kitayama T Neurochem Res; 2018 Jan; 43(1):110-115. PubMed ID: 28677029 [TBL] [Abstract][Full Text] [Related]
51. A novel GABA-mediated corticotropin-releasing hormone secretory mechanism in the median eminence. Kakizawa K; Watanabe M; Mutoh H; Okawa Y; Yamashita M; Yanagawa Y; Itoi K; Suda T; Oki Y; Fukuda A Sci Adv; 2016 Aug; 2(8):e1501723. PubMed ID: 27540587 [TBL] [Abstract][Full Text] [Related]
52. Chloride extrusion enhancers as novel therapeutics for neurological diseases. Gagnon M; Bergeron MJ; Lavertu G; Castonguay A; Tripathy S; Bonin RP; Perez-Sanchez J; Boudreau D; Wang B; Dumas L; Valade I; Bachand K; Jacob-Wagner M; Tardif C; Kianicka I; Isenring P; Attardo G; Coull JA; De Koninck Y Nat Med; 2013 Nov; 19(11):1524-8. PubMed ID: 24097188 [TBL] [Abstract][Full Text] [Related]
53. Seizing Control of KCC2: A New Therapeutic Target for Epilepsy. Moore YE; Kelley MR; Brandon NJ; Deeb TZ; Moss SJ Trends Neurosci; 2017 Sep; 40(9):555-571. PubMed ID: 28803659 [TBL] [Abstract][Full Text] [Related]
54. GABA neurotransmission and neural cation-chloride co-transporters: actions beyond ion transport. Medina I; Chudotvorova I Crit Rev Neurobiol; 2006; 18(1-2):105-12. PubMed ID: 17725513 [TBL] [Abstract][Full Text] [Related]
55. Layer-specific expression of Cl- transporters and differential [Cl-]i in newborn rat cortex. Shimizu-Okabe C; Yokokura M; Okabe A; Ikeda M; Sato K; Kilb W; Luhmann HJ; Fukuda A Neuroreport; 2002 Dec; 13(18):2433-7. PubMed ID: 12499844 [TBL] [Abstract][Full Text] [Related]
56. Anomalous levels of Cl- transporters cause a decrease of GABAergic inhibition in human peritumoral epileptic cortex. Conti L; Palma E; Roseti C; Lauro C; Cipriani R; de Groot M; Aronica E; Limatola C Epilepsia; 2011 Sep; 52(9):1635-44. PubMed ID: 21635237 [TBL] [Abstract][Full Text] [Related]
57. The Therapeutic Potential of Neuronal K-Cl Co-Transporter KCC2 in Huntington's Disease and Its Comorbidities. Andrews K; Josiah SS; Zhang J Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33266310 [TBL] [Abstract][Full Text] [Related]
58. Therapeutic restoration of spinal inhibition via druggable enhancement of potassium-chloride cotransporter KCC2-mediated chloride extrusion in peripheral neuropathic pain. Kahle KT; Khanna A; Clapham DE; Woolf CJ JAMA Neurol; 2014 May; 71(5):640-5. PubMed ID: 24615367 [TBL] [Abstract][Full Text] [Related]
59. Effects of VU0240551, a novel KCC2 antagonist, and DIDS on chloride homeostasis of neocortical neurons from rats and humans. Deisz RA; Wierschke S; Schneider UC; Dehnicke C Neuroscience; 2014 Sep; 277():831-41. PubMed ID: 25086309 [TBL] [Abstract][Full Text] [Related]